| ［1］ |
Masson E， Ewers M， Paliwal S， et al. The PRSS3P2 and TRY7 deletion copy number variant modifies risk for chronic pancreatitis［J］. Pancreatology， 2023， 23（1）: 48-56.
|
| ［2］ |
Chen Y， Wang B， Zhao Z， et al. PRSS2 overexpression relates to poor prognosis and promotes proliferation， migration and invasion in gastric cancer［J］. Tissue Cell， 2022， 79: 101949.
|
| ［3］ |
Wang J， Wan J， Wang L， et al.Wild-type human PRSS2 and PRSS1R122H cooperatively initiate spontaneous hereditary pancreatitis in transgenic mice［J］. Gastroenterology， 2022， 163（1）:313-315. e314.
|
| ［4］ |
Qin H， Zhang S， Shen L， et al. High expression of serine protease 2（PRSS2） associated with invasion， metastasis， and proliferation in gastric cancer［J］. Aging （Albany NY）， 2023， 15（7）: 2473-2484.
|
| ［5］ |
Sui L， Wang S， Ganguly D， et al. PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression［J］. Nat Commun， 2022， 13（1）: 7959.
|
| ［6］ |
Vilen ST， Suojanen J， Salas F， et al. Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP［J］. Cancer Invest， 2012， 30（8）: 583-592.
|
| ［7］ |
Yasuda H， Kataoka K， Takeyama Y， et al. Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis: A multicenter study in Japan［J］. World J Gastroenterol， 2019， 25（1）: 107-117.
|
| ［8］ |
Narasimhan A， Shahda S， Kays JK， et al. Identification of potential serum protein biomarkers and pathways for pancreatic cancer cachexia using an aptamer-based discovery platform［J］. Cancers（Basel）， 2020， 12（12）: 3787.
|
| ［9］ |
Lebedeva IV， Matsuoka Y， Al-Shareef H， et al. Effects of decreased Rac activity and malignant state on oral squamous cell carcinoma in vitro［J］. Plos One， 2021， 16（1）: e0212323.
|
| ［10］ |
Wu G， Su J， Zeng L， et al. LncRNA BCAN-AS1 stabilizes c-Myc via N6-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer［J］. Cell Death Differ， 2023， 30（10）: 2213-2230.
|
| ［11］ |
Bian B， Juiz NA， Gayet O， et al. Pancreatic cancer organoids for determining sensitivity to bromodomain and extra-terminal inhibitors （BETi）［J］. Front Oncol， 2019， 9: 475.
|
| ［12］ |
Leal AS， Liu P， Krieger-Burke T， et al. The bromodomain inhibitor， INCB057643， targets both cancer cells and the tumor microenvironment in two preclinical models of pancreatic cancer［J］. Cancers， 2020， 13（1）: 96.
|
| ［13］ |
Huang Y， Hong W， Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis［J］. J Hematol Oncol， 2022， 15（1）: 129.
|
| ［14］ |
Wang F， Yi J， Chen Y， et al. PRSS2 regulates EMT and metastasis via MMP-9 in gastric cancer［J］. Acta Histochem， 2023， 125（6）:152071.
|
| ［15］ |
El-Ashmawy NE， Khedr NF， Mansour MG， et al. TNM staging for GIT cancers is correlated with the level of MMPs and TGFbeta1［J］. Clin Exp Med， 2020， 20（4）: 545-555.
|
| ［16］ |
Sun HY， Du ST， Li YY， et al. Bromodomain and extraterminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers［J］. World J Gastrointest Oncol， 2022，14（1）: 75-89.
|
| ［17］ |
Cabot D， Brun S， Paco N， et al. KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer［J］.Oncogene， 2021， 40（38）: 5730-5740.
|
| ［18］ |
Khan E， Chakrabarty S， Shariff S， et al. Genetics and genomics of chronic pancreatitis with a focus on disease biology and molecular pathogenesis［J］. Glob Med Genet， 2023， 10（4）: 324-334.
|
| ［19］ |
Frendi S， Martineau C， Cazier H， et al. Role of the fatty pancreatic infiltration in pancreatic oncogenesis［J］. Sci Rep 2024， 14（1）:6582.
|
| ［20］ |
Xu Z， Huang Z， Zhang Y， et al. Farnesoid X receptor activation inhibits pancreatic carcinogenesis［J］. Biochim Biophys Acta Mol Basis Dis， 2023， 1869（7）: 166811.
|
| ［21］ |
Del Poggetto E， Ho IL， Balestrieri C， et al. Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis［J］. Science， 2021， 373（6561）: eabj0486.
|
| ［22］ |
Ako S， Teper Y， Ye L， et al. Statins inhibit inflammatory cytokine production by macrophages and acinar-to-ductal metaplasia of pancreatic cells［J］. Gastro Hep Advances， 2022， 1（4）: 640-651.
|
| ［23］ |
Zhou X， Xie L， Bergmann F， et al. The bile acid receptor FXR attenuates acinar cell autophagy in chronic pancreatitis［J］. Cell Death Discov， 2017， 3: 17027.
|
| ［24］ |
Wang D， Han S， Lv G， et al. Pancreatic acinar cells-derived sphingosine-1-phosphate contributes to fibrosis of chronic pancreatitis via inducing autophagy and activation of pancreatic stellate cells［J］. Gastroenterology， 2023， 165（6）: 1488-1504，e1420.
|